BHCM
CRBU icon

Boulder Hill Capital Management’s Caribou Biosciences CRBU Stock Holding History

Boulder Hill Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,400
Closed -$71.6K – 149
2022
Q4 		$71.6K Buy
+11,400
New +$101K 0.06% 121

Other funds holding CRBU

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boulder Hill Capital Management's CRBU Position: Q1 2023 in Review

Boulder Hill Capital Management sold out of Caribou Biosciences (CRBU) in Q1 2023, closing a stake of 11,400 shares — an estimated $71.6K sold.

Boulder Hill Capital Management first reported a position in CRBU in Q4 2022 and held it in 1 quarter. The position peaked at $71.6K in Q4 2022. 126 funds tracked by Wall St. Rank hold CRBU as of Q1 2023.

  • Boulder Hill Capital Management reported no remaining Caribou Biosciences position as of Q1 2023 after selling out during the quarter.
  • Boulder Hill Capital Management sold 11,400 Caribou Biosciences shares in Q1 2023, an estimated $71.6K.
  • Boulder Hill Capital Management first reported a position in Caribou Biosciences in Q4 2022 and held it in 1 quarter.
  • Boulder Hill Capital Management's Caribou Biosciences position peaked at $71.6K in Q4 2022.
  • 126 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2023.

Based on Boulder Hill Capital Management's 13F filing for Q1 2023, filed 12 May 2023.